AGP Executive Report
Last update: 3 hours agoCOVID Policy Reset: U.S. HHS says COVID-19 emergency use authorizations for drugs/biologics and devices are being terminated, with staggered end dates as FDA-approved options are now widely available. Marijuana Safety Alert: Emergency departments report a sharp rise in marijuana-induced illness, highlighting cannabinoid hyperemesis syndrome and the severe vomiting/dehydration it can cause. Weight-Loss Access: Medicare launches a time-limited “GLP-1 Bridge” pilot so eligible beneficiaries can get popular GLP-1 weight-loss drugs for $50/month through Dec. 2027, with BMI/health rules and exclusions. Hospital Workforce Reform: Spain moves to overhaul resident training rules—cutting on-call burden, reducing working hours, improving pay, and strengthening rest and mental health protections. Public Health Nutrition: Malaysia considers free drinking water at eateries as a simple way to curb sugary beverage intake and reduce obesity and diabetes risk. Wellness Tech & Care: OTC hearing aids get a new smart, touchscreen case approach, while a U.S. review highlights how wearables and AI could shift care toward prevention—if data quality holds up. Ebola Watch: UNDP warns DRC Ebola is also driving major poverty and job losses, especially for women.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
.png?width=1200&auto=webp&quality=75&trim=12,0,12,0&crop=)
